Whalegun
Home

Biomarin Pharmaceutical BMRN spent $210K on lobbying in Q2 2023 · Health Issues, Medicare

Trade details

Type
Lobbying report
Amount
$210,000
Quarter
Q2 2023
Stock
Biomarin Pharmaceutical BMRN
Client
Biomarin Pharmaceutical
Reported
23/07/20

Down 50.0% from last quarter

What else happened in Biomarin Pharmaceutical around then

Filed or reported within 30 days of the trade day · 23/05/31~23/07/30

Biomarin Pharmaceutical's other lobbying reports

Biomarin Pharmaceutical BMRN spent $210K on lobbying in Q2 2023 · Health Issues, Medicare | Whalegun